Following a successful, oversubscribed late seed funding, the company now works from labs at the Babraham Research Campus. The company’s proprietary technology, PolyNaut® can be applied to both clinical and non clinical/ex vivo products.
ViaNautis works with pharma and biotech partners for innovation and problem solving in neurology, oncology and immune diseases. Our partners Abcam PLC market and develop non-clinical products.
Founded in 2013, YAFO Capital is a Shanghai based boutique investment & advisory firm focusing on bringing global technologies to Asia. We started from investing in Israeli Medtech to China back to 2013, YAFO has established four joint ventures with our global partners in Japan, Italy, Germany, and Switzerland.
YAFO has four pillar business lines including: investment banking, fund investment, incubation, and biotech forum .
YAFO, the Hebrew word of Jaffa (now part of Tel Aviv), means beautiful. For 3500 years, the old Jaffa port has connected the ancient city with the rest of the world.
YAFO’s mission is to make our life more beautiful by introducing global technologies.
